[HTML][HTML] Validation of the particle-based multi-analyte technology for detection of anti-phosphatidylserine/prothrombin antibodies

M Radin, I Cecchi, SG Foddai, E Rubini, A Barinotti… - Biomedicines, 2020 - mdpi.com
Among “extra-criteria” antiphospholipid (aPL) antibodies, anti-phosphatidylserine/
prothrombin (aPS/PT) antibodies, are considered a part of risk assessment strategies when …

Validation of the Particle-Based Multi-Analyte Technology for Detection of Anti-PhosphatidylSerine/Prothrombin Antibodies

M Radin, I Cecchi, SG Foddai, E Rubini, A Barinotti… - 2020 - agris.fao.org
Among “extra-criteria” antiphospholipid antibodies (aPL), anti-phosphatidylserine/
prothrombin (aPS/PT) antibodies, are considered a part of risk assessment strategies when …

Validation of the Particle-Based Multi-Analyte Technology for Detection of Anti-PhosphatidylSerine/Prothrombin Antibodies

M Radin, I Cecchi, SG Foddai, E Rubini, A Barinotti… - search.proquest.com
Among “extra-criteria” antiphospholipid antibodies (aPL), anti-phosphatidylserine/
prothrombin (aPS/PT) antibodies, are considered a part of risk assessment strategies when …

Validation of the particle-based multi-analyte technology for detection of anti-phosphatidylserine/prothrombin antibodies

M Radin, I Cecchi, SG Foddai, E Rubini, A Barinotti… - BIOMEDICINES, 2020 - iris.unito.it
Among “extra-criteria” antiphospholipid antibodies (aPL), anti-phosphatidylserine/
prothrombin (aPS/PT) antibodies, are considered a part of risk assessment strategies when …

[PDF][PDF] Validation of the Particle-Based Multi-Analyte Technology for Detection of Anti-PhosphatidylSerine/Prothrombin Antibodies

M Radin, I Cecchi, SG Foddai, E Rubini, A Barinotti… - academia.edu
Among “extra-criteria” antiphospholipid (aPL) antibodies, anti-phosphatidylserine/
prothrombin (aPS/PT) antibodies, are considered a part of risk assessment strategies when …

Validation of the Particle-Based Multi-Analyte Technology for Detection of Anti-PhosphatidylSerine/Prothrombin Antibodies.

M Radin, I Cecchi, SG Foddai, E Rubini, A Barinotti… - Biomedicines, 2020 - europepmc.org
Abstract Among “extra-criteria” antiphospholipid (aPL) antibodies, anti-phosphatidylserine/
prothrombin (aPS/PT) antibodies, are considered a part of risk assessment strategies when …

[HTML][HTML] Validation of the Particle-Based Multi-Analyte Technology for Detection of Anti-PhosphatidylSerine/Prothrombin Antibodies

M Radin, I Cecchi, SG Foddai, E Rubini, A Barinotti… - …, 2020 - ncbi.nlm.nih.gov
Abstract Among “extra-criteria” antiphospholipid (aPL) antibodies, anti-phosphatidylserine/
prothrombin (aPS/PT) antibodies, are considered a part of risk assessment strategies when …

Validation of the Particle-Based Multi-Analyte Technology for Detection of Anti-PhosphatidylSerine/Prothrombin Antibodies.

M Radin, I Cecchi, SG Foddai, E Rubini… - …, 2020 - search.ebscohost.com
Abstract Among" extra-criteria" antiphospholipid (aPL) antibodies, anti-phosphatidylserine/
prothrombin (aPS/PT) antibodies, are considered a part of risk assessment strategies when …

Validation of the Particle-Based Multi-Analyte Technology for Detection of Anti-PhosphatidylSerine/Prothrombin Antibodies

M Radin, I Cecchi, SG Foddai, E Rubini… - …, 2020 - pubmed.ncbi.nlm.nih.gov
Among" extra-criteria" antiphospholipid antibodies (aPL), anti-phosphatidylserine/
prothrombin (aPS/PT) antibodies, are considered a part of risk assessment strategies when …

[PDF][PDF] Validation of the Particle-Based Multi-Analyte Technology for Detection of Anti-PhosphatidylSerine/Prothrombin Antibodies

M Radin, I Cecchi, SG Foddai, E Rubini, A Barinotti… - pdfs.semanticscholar.org
Among “extra-criteria” antiphospholipid antibodies (aPL), anti-phosphatidylserine/
prothrombin (aPS/PT) antibodies, are considered a part of risk assessment strategies when …